Browse by Author: Day, S

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 7.

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Deraos, G, Matsoukas, MT, Day, S, Stojanovska, Lily, Tselios, T, Androutsou, ME and Matsoukas, J (2017) Cyclic citrullinated MBP87–99 peptide stimulates T cell responses: Implications in triggering disease. Bioorganic and Medicinal Chemistry, 25 (2). 528 - 538. ISSN 0968-0896

Day, S, Tselios, T, Androutsou, M, Tapeinou, A, Frilligou, I, Stojanovska, Lily, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2015) Mannosylated linear and cyclic single amino acid mutant peptides using a small 10 amino acid linker constitute promising candidates against Multiple Sclerosis. Frontiers in Immunology, 6. ISSN 1664-3224

Stojanovska, Lily, Law, C, Lai, B, Chung, T, Nelson, K, Day, S, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Haines, C (2015) Maca reduces blood pressure and depression, in a pilot study in postmenopausal women. Climacteric, 18 (1). 69 - 78. ISSN 1369-7137

Sheng, KC, Day, S, Wright, MD, Stojanovska, Lily and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2013) Enhanced Dendritic Cell-Mediated Antigen-Specific CD4+ T Cell Responses: IFN-Gamma Aids TLR Stimulation. Journal of drug delivery, 2013. ISSN 2090-3014

Wilkinson, BL, Day, S, Chapman, Robert, Perrier, S, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Payne, RJ (2012) Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates. Chemistry - A European Journal, 18 (51). 16540 - 16548. ISSN 0947-6539

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Katsara, M, Day, S, Tselios, T and Matsoukas, J (2012) Immunotherapeutic aspects for MS: are we heading in the right direction? In: Progress in MS Research Conference 2011, 26 October 2011-28 October 2011, Melbourne, Australia.

Wilkinson, BL, Day, S, Malins, LR, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Payne, RJ (2011) Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-Like Receptor 2 Agonist Pam3CysSer. Angewandte Chemie - International Edition, 50 (7). 1635 - 1639. ISSN 1433-7851